Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > RMD timing

<< Previous

Bullboard Posts

Next >>

Comment by Lee430on Dec 16, 2022 1:49pm

82 Views

Post# 35176340

RE:RE:RMD timing

Well transfer in-kind it is......gonna need to tighten the budget a bit as this WAS part of my retiremt income.

SABBOBCAT wrote:
If it you have the means, you can take the RMD in kind, can't you? Hitting the bid might not be fun before the end of the year.

Lee430 wrote: I need to sell about 7K shares of THTX soon for this year’s RMD, was holding out for some positive PR from Thera hoping for at least a little bump before selling…..Any thoughts on whether I should pull the trigger now or hold out a bit longer?